SICOB Italian clinical practice guidelines for the surgical treatment of obesity and associated diseases using GRADE methodology on bariatric and metabolic surgery.
Bariatric surgery
Guidelines
Obesity
Journal
Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818
Informations de publication
Date de publication:
17 Oct 2024
17 Oct 2024
Historique:
accepted:
09
09
2024
medline:
18
10
2024
pubmed:
18
10
2024
entrez:
17
10
2024
Statut:
aheadofprint
Résumé
Obesity is a chronic disease associated with increased morbidity and mortality and reduced quality of life. Pharmacotherapy can be associated with life style changes in increasing and maintaining weight loss and ameliorating obesity-related complications and comorbidities. In patients affected by obesity and uncontrolled obesity-associated complications or high degrees of BMI (> 40 Kg/m
Identifiants
pubmed: 39419949
doi: 10.1007/s13304-024-01996-z
pii: 10.1007/s13304-024-01996-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Italian Society of Surgery (SIC).
Références
Jaacks LM, Vandevijvere S, Pan A et al (2019) The obesity transition: stages of the global epidemic. Lancet Diabetes Endocrinol 7(3):231–240
pubmed: 30704950
pmcid: 7360432
doi: 10.1016/S2213-8587(19)30026-9
Wadden TA, Tronieri JS, Butryn ML (2020) Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol 75(2):235–251
pubmed: 32052997
pmcid: 7027681
doi: 10.1037/amp0000517
de Raaff CAL, Gorter-Stam MAW, de Vries N et al (2017) Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline. Surg Obes Relat Dis 13(7):1095–1109
pubmed: 28666588
doi: 10.1016/j.soard.2017.03.022
Pineda E, Sanchez-Romero LM, Brown M, et al (2018) Forecasting future trends in obesity across Europe: The value of improving surveillance. Obes Facts 11(5):360-371. https://doi.org/10.1159/000492115 .
Guyatt GH, Oxman AD, Santesso N et al (2013) GRADE guidelines: 12 Preparing summary of findings tables-binary outcomes. J Clin Epidemiol 66(2):158–72
pubmed: 22609141
doi: 10.1016/j.jclinepi.2012.01.012
Di Lorenzo N, Antoniou SA, Batterham RL et al (2020) Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC. EASO and ESPCOP Surg Endosc 34(6):2332–2358
pubmed: 32328827
doi: 10.1007/s00464-020-07555-y
De Luca M, Zappa MA, Zese M, et al (2020) Development of the Italian Clinical Practice Guidelines on Bariatric and Metabolic Surgery: Design and Methodological Aspects. Nutrients 15(1):189. https://doi.org/10.3390/nu15010189 .
Brozek JL, Akl EA, Alonso-Coello P et al (2009) Grading quality of evidence and strength of recommendations in clinical practice guidelines Part 1 of 3 An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 64(5):669–77
pubmed: 19210357
doi: 10.1111/j.1398-9995.2009.01973.x
de Villiers MR, de Villiers PJ, Kent AP (2005) The Delphi technique in health sciences education research. Med Teach 27(7):639–643
pubmed: 16332558
doi: 10.1080/13611260500069947
Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed) 336(7650):924–926
pubmed: 18436948
doi: 10.1136/bmj.39489.470347.AD
Alonso-Coello P, Schünemann HJ, Moberg J et al (2016) GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices 1: Introduction. BMJ (Clinical research ed) 353:i2016
pubmed: 27353417
Buse JB, Caprio S, Cefalu WT et al (2009) How do we define cure of diabetes? Diabetes Care 32(11):2133–2135
pubmed: 19875608
pmcid: 2768219
doi: 10.2337/dc09-9036
Disease C, Management R (2018) Standards of Medical Care in Diabetes-2018. Diabetes Care 41(Suppl 1):S86-s104
Morgenthaler TI, Kapen S, Lee-Chiong T et al (2006) Practice parameters for the medical therapy of obstructive sleep apnea. Sleep 29(8):1031–1035
pubmed: 16944671
doi: 10.1093/sleep/29.8.1031
WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand 1977; 56(3): 247–53.
Cresci B, Cosentino C, Monami M, Mannucci E (2020) Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials. Diabetes Obes Metab 22(8):1378–1387. https://doi.org/10.1111/dom.14045 .
pubmed: 32243058
doi: 10.1111/dom.14045
Dixon JB, le Roux CW, Rubino F, Zimmet P (2012) Bariatric surgery for type 2 diabetes. Lancet 379(9833):2300–2311
pubmed: 22683132
doi: 10.1016/S0140-6736(12)60401-2
Cohen RV, Pereira TV, Aboud CM et al (2020) Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial. JAMA Surg 155(8):e200420
pubmed: 32492126
pmcid: 7270872
doi: 10.1001/jamasurg.2020.0420
Parikh M, Chung M, Sheth S et al (2014) Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg 260(4):617–22
pubmed: 25203878
doi: 10.1097/SLA.0000000000000919
Spaggiari M, Di Cocco P, Tulla K et al (2021) Simultaneous robotic kidney transplantation and bariatric surgery for morbidly obese patients with end-stage renal failure. Am J Transplant 21(4):1525–1534
pubmed: 32976702
doi: 10.1111/ajt.16322
Mingrone G, Panunzi S, De Gaetano A et al (2021) Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 397(10271):293–304
doi: 10.1016/S0140-6736(20)32649-0
Stival C, Lugo A, Odone A et al (2022) Prevalence and correlates of overweight and obesity in 12 European Countries in 2017–2018. Obes Facts 15(5):655–665
pubmed: 35917801
pmcid: 9669997
doi: 10.1159/000525792
Mechanick JI, Apovian C, Brethauer S et al (2020) Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures—2019 update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring) 28(4):O1-o58
pubmed: 32202076
doi: 10.1002/oby.22719
O’Brien PE, Brennan L, Laurie C, Brown W (2013) Intensive medical weight loss or laparoscopic adjustable gastric banding in the treatment of mild to moderate obesity: long-term follow-up of a prospective randomised trial. Obes Surg 23(9):1345–1353
pubmed: 23760764
doi: 10.1007/s11695-013-0990-3
Dixon JB, Schachter LM, O’Brien PE et al (2012) Surgical vs conventional therapy for weight loss treatment of obstructive sleep apnea: a randomized controlled trial. JAMA 308(11):1142–1149
pubmed: 22990273
doi: 10.1001/2012.jama.11580
Feigel-Guiller B, Drui D, Dimet J et al (2015) Laparoscopic gastric banding in obese patients with sleep Apnea: A 3-year controlled study and follow-up after 10 years. Obes Surg 25(10):1886–1892
pubmed: 25702144
doi: 10.1007/s11695-015-1627-5
MacLaughlin HL, Hall WL, Patel AG et al (2014) Weight loss, adipokines, and quality of life after sleeve gastrectomy in obese patients with stages 3–4 CKD: a randomized controlled pilot study. Am J Kidney Dis 64(4):660–663
pubmed: 25085646
doi: 10.1053/j.ajkd.2014.06.011
Mollan SP, Mitchell JL, Ottridge RS et al (2021) Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol 78(6):678–686
pubmed: 33900360
pmcid: 8077040
doi: 10.1001/jamaneurol.2021.0659
Dowsey MM, Brown WA, Cochrane A, Burton PR, Liew D, Choong PF (2022) Effect of bariatric surgery on risk of complications after total knee arthroplasty: a randomized clinical trial. JAMA Netw Open 5(4):e226722
pubmed: 35420662
pmcid: 9011119
doi: 10.1001/jamanetworkopen.2022.6722
Schauer DP, Arterburn DE, Livingston EH et al (2015) Impact of bariatric surgery on life expectancy in severely obese patients with diabetes: a decision analysis. Ann Surg 261(5):914–919
pubmed: 25844968
doi: 10.1097/SLA.0000000000000907
Garrido-Miguel M, Cavero-Redondo I, Álvarez-Bueno C et al (2019) Prevalence and trends of overweight and obesity in european children from 1999 to 2016: a systematic review and meta-analysis. JAMA Pediatr 173(10):e192430
pubmed: 31381031
pmcid: 6686782
doi: 10.1001/jamapediatrics.2019.2430
Torbahn G, Brauchmann J, Axon E et al (2022) Surgery for the treatment of obesity in children and adolescents. Cochrane Database Syst Rev 9(9):cd011740
pubmed: 36074911
O’Brien PE, Sawyer SM, Laurie C et al (2010) Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA 303(6):519–526
pubmed: 20145228
doi: 10.1001/jama.2010.81
Peralta M, Ramos M, Lipert A, Martins J, Marques A (2018) Prevalence and trends of overweight and obesity in older adults from 10 European countries from 2005 to 2013. Scand J Public Health 46(5):522–529
pubmed: 29569525
doi: 10.1177/1403494818764810
Giordano S, Victorzon M (2015) Bariatric surgery in elderly patients: a systematic review. Clin Interv Aging 10:1627–1635
pubmed: 26508845
pmcid: 4610711
Medeiros VG, Pajecki D, Dias MCG, Dantas ACB, Cleva R, Santo MA (2022) FOOD TOLERANCE AND NUTRITIONAL RISK AFTER SLEEVE GASTRECTOMY AND ROUX-EN-Y GASTRIC BYPASS IN ELDERLY PATIENTS WITH SEVERE OBESITY: A PROSPECTIVE RANDOMIZED CONTROLLED TRIAL. Arq Gastroenterol 59(3):370–374
pubmed: 36102434
doi: 10.1590/s0004-2803.202203000-67
Borgeraas H, Hjelmesæth J, Birkeland KI et al (2019) Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function in subjects with morbid obesity: a protocol for the Obesity surgery in Tønsberg (Oseberg) study. BMJ Open 9(6):e024573
pubmed: 31167860
pmcid: 6561424
doi: 10.1136/bmjopen-2018-024573
El-Hadi M, Birch DW, Gill RS, Karmali S (2014) The effect of bariatric surgery on gastroesophageal reflux disease. Can J Surg 57(2):139–144
pubmed: 24666452
pmcid: 3968207
doi: 10.1503/cjs.030612
Darabi S, Talebpour M, Zeinoddini A, Heidari R (2013) Laparoscopic gastric plication versus mini-gastric bypass surgery in the treatment of morbid obesity: a randomized clinical trial. Surg Obes Relat Dis 9(6):914–919
pubmed: 24321569
doi: 10.1016/j.soard.2013.07.012
Eskandaros MS, Abbass A, Zaid MH, Darwish AA (2021) Laparoscopic one anastomosis gastric bypass versus laparoscopic Roux-en-Y gastric bypass effects on pre-existing mild-to-moderate gastroesophageal reflux disease in patients with obesity: a randomized controlled study. Obes Surg 31(11):4673–4681
pubmed: 34406598
doi: 10.1007/s11695-021-05667-5
Biter LU, van Buuren MMA, Mannaerts GHH, Apers JA, Dunkelgrün M, Vijgen G (2017) Quality of Life 1 year after laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass: a randomized controlled trial focusing on gastroesophageal reflux disease. Obes Surg 27(10):2557–2565
pubmed: 28474319
doi: 10.1007/s11695-017-2688-4
Kehagias I, Karamanakos SN, Argentou M, Kalfarentzos F (2011) Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the management of patients with BMI < 50 kg/m2. Obes Surg 21(11):1650–1656
pubmed: 21818647
doi: 10.1007/s11695-011-0479-x
Lorentzen J, Medhus AW, Hofsø D, Svanevik M, Seip B, Hjelmesæth J (2021) Sleeve gastrectomy confers higher risk of gastroesophageal reflux disease than gastric bypass: a randomized controlled trial from the oseberg reflux working group. Gastroenterology 161(6):2044–6.e4
pubmed: 34419459
doi: 10.1053/j.gastro.2021.08.021
Peterli R, Wölnerhanssen BK, Peters T et al (2018) Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: The SM-BOSS randomized clinical trial. JAMA 319(3):255–265
pubmed: 29340679
pmcid: 5833546
doi: 10.1001/jama.2017.20897
Li J, Lai D, Wu D (2016) Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg 26(2):429–442
pubmed: 26661105
doi: 10.1007/s11695-015-1996-9
Panunzi S, Maltese S, De Gaetano A, Capristo E, Bornstein SR, Mingrone G (2021) Comparative efficacy of different weight loss treatments on knee osteoarthritis: a network meta-analysis. Obes Rev 22(8):e13230
pubmed: 33855769
doi: 10.1111/obr.13230
Lin MY, Tavakol MM, Sarin A et al (2013) Laparoscopic sleeve gastrectomy is safe and efficacious for pretransplant candidates. Surg Obes Relat Dis 9(5):653–658
pubmed: 23701857
doi: 10.1016/j.soard.2013.02.013
Lopez-Lopez V, Ruiz-Manzanera JJ, Eshmuminov D et al (2021) Are we ready for bariatric surgery in a liver transplant program? a meta-analysis. Obes Surg 31(3):1214–1222
pubmed: 33225408
doi: 10.1007/s11695-020-05118-7
Lee Y, Anvari S, Sam Soon M et al (2022) Bariatric surgery as a bridge to heart transplantation in morbidly obese patients: a systematic review and meta-analysis. Cardiol Rev 30(1):1–7
pubmed: 33165086
doi: 10.1097/CRD.0000000000000346
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578
pubmed: 18280327
doi: 10.1016/S0140-6736(08)60269-X
Sjöholm K, Carlsson LMS, Svensson PA et al (2022) Association of bariatric surgery with cancer incidence in patients with obesity and diabetes: long-term results from the swedish obese subjects study. Diabetes Care 45(2):444–450
pubmed: 34799430
doi: 10.2337/dc21-1335
Cheng A, Yeoh E, Moh A et al (2022) Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg/m(2): a 5-year randomized controlled trial. Diabetes Res Clin Pract 188:109900
pubmed: 35513159
doi: 10.1016/j.diabres.2022.109900
Courcoulas AP, Gallagher JW, Neiberg RH et al (2020) Bariatric surgery vs lifestyle intervention for diabetes treatment: 5-Year outcomes from a randomized trial. J Clin Endocrinol Metab 105(3):866–876
pmcid: 7032894
doi: 10.1210/clinem/dgaa006
Cummings DE, Arterburn DE, Westbrook EO et al (2016) Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial. Diabetologia 59(5):945–953
pubmed: 26983924
pmcid: 4826815
doi: 10.1007/s00125-016-3903-x
Dixon JB, O’Brien PE, Playfair J et al (2008) Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 299(3):316–323
pubmed: 18212316
doi: 10.1001/jama.299.3.316
Ikramuddin S, Korner J, Lee WJ et al (2018) Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A1c, LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study. JAMA 319(3):266–278
pubmed: 29340678
pmcid: 5833547
doi: 10.1001/jama.2017.20813
Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X (2013) Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract 101(1):50–56
pubmed: 23706413
doi: 10.1016/j.diabres.2013.04.005
Miller K, Turró R, Greve JW, Bakker CM, Buchwald JN, Espinós JC (2017) MILEPOST multicenter randomized controlled trial: 12-month weight loss and satiety outcomes after pose (SM) vs. Med Ther Obes Surg 27(2):310–322
doi: 10.1007/s11695-016-2295-9
Schauer PR, Bhatt DL, Kirwan JP et al (2017) Bariatric surgery versus intensive medical therapy for diabetes—5-Year Outcomes. N Engl J Med 376(7):641–651
pubmed: 28199805
pmcid: 5451258
doi: 10.1056/NEJMoa1600869
Schiavon CA, Bhatt DL, Ikeoka D et al (2020) Three-year outcomes of bariatric surgery in patients with obesity and hypertension : a randomized clinical trial. Ann Intern Med 173(9):685–693
pubmed: 32805133
doi: 10.7326/M19-3781
Simonson DC, Vernon A, Foster K, Halperin F, Patti ME, Goldfine AB (2019) Adjustable gastric band surgery or medical management in patients with type 2 diabetes and obesity: three-year results of a randomized trial. Surg Obes Relat Dis 15(12):2052–2059
pubmed: 31931977
doi: 10.1016/j.soard.2019.03.038
Thompson CC, Abu Dayyeh BK, Kushner R et al (2017) Percutaneous gastrostomy device for the treatment of class II and class III obesity: results of a randomized controlled trial. Am J Gastroenterol 112(3):447–457
pubmed: 27922026
doi: 10.1038/ajg.2016.500
Nagappa M, Patra J, Wong J et al (2017) Association of STOP-bang questionnaire as a screening tool for sleep Apnea and postoperative complications: a systematic review and bayesian meta-analysis of prospective and retrospective cohort studies. Anesth Analg 125(4):1301–1308
pubmed: 28817421
doi: 10.1213/ANE.0000000000002344
Hwang M, Nagappa M, Guluzade N, Saripella A, Englesakis M, Chung F (2022) Validation of the STOP-Bang questionnaire as a preoperative screening tool for obstructive sleep apnea: a systematic review and meta-analysis. BMC Anesthesiol 22(1):366
pubmed: 36451106
pmcid: 9710034
doi: 10.1186/s12871-022-01912-1
de Carvalho TR, Blume CA, Alessi J, Schaan BD, Telo GH (2022) Polysomnography in pre-operative screening for obstructive sleep apnea in patients undergoing bariatric surgery: a retrospective cohort study. Int J Obes (Lond) 46(4):802–808
pubmed: 34983957
doi: 10.1038/s41366-021-01055-2
O’Reilly E, Doherty L, O’Boyle C (2020) How relevant is pre-operative obstructive sleep apnoea in the asymptomatic bariatric surgery patient? Obes Surg 30(3):969–974
pubmed: 31758473
doi: 10.1007/s11695-019-04291-8
Meurgey JH, Brown R, Woroszyl-Chrusciel A, Steier J (2018) Peri-operative treatment of sleep-disordered breathing and outcomes in bariatric patients. J Thorac Dis 10(Suppl 1):S144–S152
pubmed: 29445538
pmcid: 5803041
doi: 10.21037/jtd.2017.10.11
Gaszynski T, Tokarz A, Piotrowski D, Machala W (2007) Boussignac CPAP in the postoperative period in morbidly obese patients. Obes Surg 17(4):452–456
pubmed: 17608255
doi: 10.1007/s11695-007-9079-1
Guimarães J, Pinho D, Nunes CS, Cavaleiro CS, Machado HS (2016) Effect of Boussignac continuous positive airway pressure ventilation on Pao2 and Pao2/Fio2 ratio immediately after extubation in morbidly obese patients undergoing bariatric surgery: a randomized controlled trial. J Clin Anesth 34:562–570
pubmed: 27687452
doi: 10.1016/j.jclinane.2016.06.024
Sekhar N, Torquati A, Lutfi R, Richards WO (2006) Endoscopic evaluation of the gastrojejunostomy in laparoscopic gastric bypass A series of 340 patients without postoperative leak. Surg Endosc 20(2):199–201
pubmed: 16333555
doi: 10.1007/s00464-005-0118-5
Lee Y, Dang JT, Switzer N, Malhan R, Birch DW, Karmali S (2019) Bridging interventions before bariatric surgery in patients with BMI ≥ 50 kg/m(2): a systematic review and meta-analysis. Surg Endosc 33(11):3578–3588
pubmed: 31399947
doi: 10.1007/s00464-019-07027-y
Pavlovic N, Boland RA, Brady B et al (2021) Effect of weight-loss diets prior to elective surgery on postoperative outcomes in obesity: A systematic review and meta-analysis. Clin Obes 11(6):e12485
pubmed: 34463422
pmcid: 9286439
doi: 10.1111/cob.12485
Kalarchian MA, Marcus MD, Courcoulas AP, Cheng Y, Levine MD (2016) Preoperative lifestyle intervention in bariatric surgery: a randomized clinical trial. Surg Obes Relat Dis 12(1):180–187
pubmed: 26410538
doi: 10.1016/j.soard.2015.05.004
Solomon H, Liu GY, Alami R, Morton J, Curet MJ (2009) Benefits to patients choosing preoperative weight loss in gastric bypass surgery: new results of a randomized trial. J Am Coll Surg 208(2):241–245
pubmed: 19228536
doi: 10.1016/j.jamcollsurg.2008.09.028
Van Nieuwenhove Y, Dambrauskas Z, Campillo-Soto A et al (2011) Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study. Arch Surg 146(11):1300–1305
pubmed: 22106323
doi: 10.1001/archsurg.2011.273
Vicente Martin C, Rabago Torre LR, Castillo Herrera LA et al (2020) Preoperative intragastric balloon in morbid obesity is unable to decrease early postoperative morbidity of bariatric surgery (sleeve gastrectomy and gastric bypass): a clinical assay. Surg Endosc 34(6):2519–2531
pubmed: 31399943
doi: 10.1007/s00464-019-07061-w
Stein PD, Matta F (2013) Pulmonary embolism and deep venous thrombosis following bariatric surgery. Obes Surg 23(5):663–668
pubmed: 23404239
doi: 10.1007/s11695-012-0854-2
Abdelsalam AM, ElAnsary A, Salman MA, Nassef SA, Elfergany HM, Aisha HAA (2021) Adding a preoperative dose of LMWH may decrease VTE following bariatric surgery. World J Surg 45(1):126–131
pubmed: 32989579
doi: 10.1007/s00268-020-05782-x
Ahmad KS, Zayed ME, Faheem MH, Essa MS (2021) Incidence of silent deep venous thrombosis after laparoscopic bariatric surgery in patients who received combined mechanical and chemical thromboprophylaxis compared to patients who received mechanical thromboprophylaxis only. Surg Innov 28(1):144–150
pubmed: 33035103
doi: 10.1177/1553350620965812
Imberti D, Baldini E, Pierfranceschi MG et al (2014) Prophylaxis of venous thromboembolism with low molecular weight heparin in bariatric surgery: a prospective, randomised pilot study evaluating two doses of parnaparin (BAFLUX Study). Obes Surg 24(2):284–291
pubmed: 24163189
doi: 10.1007/s11695-013-1105-x
Kalfarentzos F, Stavropoulou F, Yarmenitis S et al (2001) Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg 11(6):670–676
pubmed: 11775562
doi: 10.1381/09608920160558588
Steib A, Degirmenci SE, Junke E et al (2016) Once versus twice daily injection of enoxaparin for thromboprophylaxis in bariatric surgery: effects on antifactor Xa activity and procoagulant microparticles A randomized controlled study. Surg Obes Relat Dis 12(3):613–21
pubmed: 26686309
doi: 10.1016/j.soard.2015.08.505
Gandra S, Trett A, Alvarez-Uria G, Solomkin JS, Laxminarayan R (2019) Is the efficacy of antibiotic prophylaxis for surgical procedures decreasing? Systematic review and meta-analysis of randomized control trials. Infect Control Hosp Epidemiol 40(2):133–141
pubmed: 30417800
doi: 10.1017/ice.2018.295
Rotman N, Hay JM, Lacaine F, Fagniez PL (1989) Prophylactic antibiotherapy in abdominal surgery First- vs third-generation cephalosporins. Arch Surg 124(3):323–327
pubmed: 2493239
doi: 10.1001/archsurg.1989.01410030073012
Gaskill HV 3rd, Levine BA (1989) A randomized prospective study of antibiotic prophylaxis during abdominal surgery. J Antimicrob Chemother 23(Suppl D):79–83
pubmed: 2722726
doi: 10.1093/jac/23.suppl_D.79
Kow L, Toouli J, Brookman J, McDonald PJ (1995) Comparison of cefotaxime plus metronidazole versus cefoxitin for prevention of wound infection after abdominal surgery. World J Surg 19(5):680–6
pubmed: 7571663
doi: 10.1007/BF00295902
Luke M, Iversen J, Søndergaard J et al (1991) Ceftriaxone vs. ampicillin + metronidazole as prophylaxis against infections after clean-contaminated abdominal surgery. Eur J Surg 157(1):45–9
pubmed: 1675881
Marti MC, Auckenthaler R (1983) Antibiotic prophylaxis in large bowel surgery: results of a controlled clinical trial. Surgery 93(1 Pt 2):190–196
pubmed: 6336862
Menzies D, Gilbert JM, Shepherd MJ, Rogers TR (1989) A comparison between amoxycillin/clavulanate and mezlocillin in abdominal surgical prophylaxis. J Antimicrob Chemother 24(Suppl B):203–8
pubmed: 2691481
doi: 10.1093/jac/24.suppl_B.203
Paladino JA, Rainstein MA, Serrianne DJ et al (1994) Ampicillin-sulbactam versus cefoxitin for prophylaxis in high-risk patients undergoing abdominal surgery. Pharmacotherapy 14(6):734–739
pubmed: 7885978
doi: 10.1002/j.1875-9114.1994.tb04167.x
Plouffe JF (1989) Cefmetazole versus cefoxitin in prevention of infections after abdominal surgery. J Antimicrob Chemother 23(Suppl D):85–8
pubmed: 2722727
doi: 10.1093/jac/23.suppl_D.85
Shatney CH (1984) Antibiotic prophylaxis in elective gastro-intestinal tract surgery: a comparison of single-dose pre-operative cefotaxime and multiple-dose cefoxitin. J Antimicrob Chemother 14(Suppl B):241–5
pubmed: 6094447
doi: 10.1093/jac/14.suppl_B.241
Tonelli F, Mazzei T, Novelli A, Mazzoni P, Ficari F (2002) Amoxicillin/clavulanic acid versus cefotaxime for antimicrobial prophylaxis in abdominal surgery: a randomized trial. J Chemother 14(4):366–372
pubmed: 12420854
doi: 10.1179/joc.2002.14.4.366
Woodfield JC, Van Rij AM, Pettigrew RA, van der Linden AJ, Solomon C, Bolt D (2003) A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. Am J Surg 185(1):45–49
pubmed: 12531444
doi: 10.1016/S0002-9610(02)01125-X
Di Saverio S (2011) Evidence-based review of enhancing postoperative recovery after breast surgery (Br J Surg 2011; 98: 181–196). Br J Surg 98(2):197
pubmed: 21182041
doi: 10.1002/bjs.7338
Papasavas P, Seip RL, McLaughlin T et al (2023) A randomized controlled trial of an enhanced recovery after surgery protocol in patients undergoing laparoscopic sleeve gastrectomy. Surg Endosc 37(2):921–931
pubmed: 36050610
doi: 10.1007/s00464-022-09512-3
Prabhakaran S, Misra S, Magila M et al (2020) Randomized controlled trial comparing the outcomes of enhanced recovery after surgery and standard recovery pathways in laparoscopic sleeve gastrectomy. Obes Surg 30(9):3273–3279
pubmed: 32291702
doi: 10.1007/s11695-020-04585-2
Ruiz-Tovar J, Garcia A, Ferrigni C, Gonzalez J, Castellon C, Duran M (2019) Impact of implementation of an enhanced recovery after surgery (ERAS) program in laparoscopic Roux-en-Y gastric bypass: a prospective randomized clinical trial. Surg Obes Relat Dis 15(2):228–235
pubmed: 30606469
doi: 10.1016/j.soard.2018.11.002
Geubbels N, Evren I, Acherman YIZ et al (2019) Randomized clinical trial of an enhanced recovery after surgery programme versus conventional care in laparoscopic Roux-en-Y gastric bypass surgery. BJS Open 3(3):274–281
pubmed: 31183442
pmcid: 6551390
doi: 10.1002/bjs5.50143
Pimenta GP, Capellan DA, de Aguilar-Nascimento JE (2015) Sleeve gastrectomy with or without a multimodal perioperative care a randomized pilot study. Obes Surg 25(9):1639–1646
pubmed: 25670530
doi: 10.1007/s11695-015-1573-2
Lemanu DP, Singh PP, Berridge K et al (2013) Randomized clinical trial of enhanced recovery versus standard care after laparoscopic sleeve gastrectomy. Br J Surg 100(4):482–489
pubmed: 23339040
doi: 10.1002/bjs.9026
Stowers MD, Lemanu DP, Hill AG (2015) Health economics in enhanced recovery after surgery programs. Can J Anaesth 62(2):219–230
pubmed: 25391739
doi: 10.1007/s12630-014-0272-0
Aasheim ET, Björkman S, Søvik TT et al (2009) Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr 90(1):15–22
pubmed: 19439456
doi: 10.3945/ajcn.2009.27583
Ben-Porat T, Weiss R, Khalaileh A et al (2021) The impact of preoperative vitamin administration on skeletal status following sleeve gastrectomy in young and middle-aged women: a randomized controlled trial. Int J Obes (Lond) 45(9):1925–1936
pubmed: 33980995
doi: 10.1038/s41366-021-00845-y
Cordeiro A, Pereira SE, Saboya CJ, Ramalho A (2022) Vitamin D supplementation and its relationship with loss of visceral adiposity. Obes Surg 32(10):3419–3425
pubmed: 35953634
doi: 10.1007/s11695-022-06239-x
Dogan K, Aarts EO, Koehestanie P et al (2014) Optimization of vitamin suppletion after Roux-en-Y gastric bypass surgery can lower postoperative deficiencies: a randomized controlled trial. Medicine (Baltimore) 93(25):e169
pubmed: 25437032
pmcid: 4616370
doi: 10.1097/MD.0000000000000169
Goldner WS, Stoner JA, Lyden E et al (2009) Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg 19(2):173–179
pubmed: 18795378
doi: 10.1007/s11695-008-9680-y
Heusschen L, Schijns W, Ploeger N et al (2020) The true story on deficiencies after sleeve gastrectomy: results of a double-blind RCT. Obes Surg 30(4):1280–1290
pubmed: 31776782
doi: 10.1007/s11695-019-04252-1
Carlin AM, Rao DS, Yager KM, Parikh NJ, Kapke A (2009) Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis 5(4):444–449
pubmed: 18996761
doi: 10.1016/j.soard.2008.08.004
Muschitz C, Kocijan R, Haschka J et al (2016) The impact of Vitamin D, calcium, protein supplementation, and physical exercise on bone metabolism after bariatric surgery: the BABS study. J Bone Miner Res 31(3):672–682
pubmed: 26350034
doi: 10.1002/jbmr.2707
Yang H, Petersen GM, Roth MP, Schoenfield LJ, Marks JW (1992) Risk factors for gallstone formation during rapid loss of weight. Dig Dis Sci 37(6):912–918
pubmed: 1587196
doi: 10.1007/BF01300390
Mulliri A, Menahem B, Alves A, Dupont B (2022) Ursodeoxycholic acid for the prevention of gallstones and subsequent cholecystectomy after bariatric surgery: a meta-analysis of randomized controlled trials. J Gastroenterol 57(8):529–539
pubmed: 35704084
doi: 10.1007/s00535-022-01886-4
Haal S, Guman MSS, de Brauw LM et al (2022) Cost-effectiveness of ursodeoxycholic acid in preventing new-onset symptomatic gallstone disease after Roux-en-Y gastric bypass surgery. Br J Surg 109(11):1116–1123
pubmed: 35979609
pmcid: 10364680
doi: 10.1093/bjs/znac273
Casajoana A, Guerrero-Pérez F, Ruiz García, de Gordejuela A et al (2021) Role of gastrointestinal hormones as a predictive factor for long-term diabetes remission: randomized trial comparing metabolic gastric bypass sleeve gastrectomy and greater curvature plication. Obes Surg 31(4):1733–44
doi: 10.1007/s11695-020-05192-x
Catheline JM, Fysekidis M, Bendacha Y et al (2019) Prospective, multicentric, comparative study between sleeve gastrectomy and Roux-en-Y gastric bypass, 277 patients, 3 years follow-up. J Visc Surg 156(6):497–506
pubmed: 31103560
doi: 10.1016/j.jviscsurg.2019.04.013
Grubnik VV, Ospanov OB, Namaeva KA, Medvedev OV, Kresyun MS (2016) Randomized controlled trial comparing laparoscopic greater curvature plication versus laparoscopic sleeve gastrectomy. Surg Endosc 30(6):2186–2191
pubmed: 26541724
doi: 10.1007/s00464-015-4373-9
Hofsø D, Fatima F, Borgeraas H et al (2019) Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol 7(12):912–924
doi: 10.1016/S2213-8587(19)30344-4
Jain M, Tantia O, Goyal G et al (2021) LSG vs MGB-OAGB: 5-year follow-up data and comparative outcome of the two procedures over long term-results of a randomised control trial. Obes Surg 31(3):1223–1232
pubmed: 33200309
doi: 10.1007/s11695-020-05119-6
Keidar A, Hershkop KJ, Marko L et al (2013) Roux-en-Y gastric bypass vs sleeve gastrectomy for obese patients with type 2 diabetes: a randomised trial. Diabetologia 56(9):1914–1918
doi: 10.1007/s00125-013-2965-2
Level L, Rojas A, Piñango S, Avariano Y (2021) One anastomosis gastric bypass vs. Roux-en-Y gastric bypass: a 5-year follow-up prospective randomized trial. Langenbecks Arch Surg 406(1):171–9
pubmed: 32761373
doi: 10.1007/s00423-020-01949-1
Murphy R, Plank LD, Clarke MG et al (2022) Effect of banded Roux-en-Y gastric bypass versus sleeve gastrectomy on diabetes remission at 5 years among patients with obesity and type 2 diabetes: a blinded randomized clinical trial. Diabetes Care 45(7):1503–1511
pubmed: 35554515
pmcid: 9274222
doi: 10.2337/dc21-2498
Paluszkiewicz R, Kalinowski P, Wróblewski T et al (2012) Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastric bypass for the management of patients with morbid obesity. Wideochir Inne Tech Maloinwazyjne 7(4):225–232
pubmed: 23362420
pmcid: 3557743
Robert M, Espalieu P, Pelascini E et al (2019) Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial. Lancet 393(10178):1299–1309
pubmed: 30851879
doi: 10.1016/S0140-6736(19)30475-1
Roushdy A, Abdel-Razik MA, Emile SH et al (2020) Fasting Ghrelin and Postprandial GLP-1 levels in patients with morbid obesity and medical comorbidities after sleeve gastrectomy and one-anastomosis gastric bypass: a randomized clinical trial. Surg Laparosc Endosc Percutan Tech 31(1):28–35
pubmed: 32810030
doi: 10.1097/SLE.0000000000000844
Salminen P, Grönroos S, Helmiö M et al (2022) Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial. JAMA Surg 157(8):656–666
pubmed: 35731535
pmcid: 9218929
doi: 10.1001/jamasurg.2022.2229
Skroubis G, Kouri N, Mead N, Kalfarentzos F (2014) Long-term results of a prospective comparison of Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population (BMI 35–50 kg/m(2)). Obes Surg 24(2):197–204
pubmed: 24105406
doi: 10.1007/s11695-013-1081-1
Wallenius V, Alaraj A, Björnfot N et al (2020) Sleeve gastrectomy and Roux-en-Y gastric bypass in the treatment of type 2 diabetes Two-year results from a Swedish multicenter randomized controlled trial. Surg Obes Relat Dis 16(8):1035–44
doi: 10.1016/j.soard.2020.04.033
Hedberg J, Sundbom M (2012) Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass–a randomized controlled trial. Surg Obes Relat Dis 8(3):338–343
pubmed: 22425057
doi: 10.1016/j.soard.2012.01.014
Horbach T, Meyer G, Morales-Conde S et al (2016) Closed-loop gastric electrical stimulation versus laparoscopic adjustable gastric band for the treatment of obesity: a randomized 12-month multicenter study. Int J Obes (Lond) 40(12):1891–1898
pubmed: 27633147
doi: 10.1038/ijo.2016.159
Ignat M, Vix M, Imad I et al (2017) Randomized trial of Roux-en-Y gastric bypass versus sleeve gastrectomy in achieving excess weight loss. Br J Surg 104(3):248–256
pubmed: 27901287
doi: 10.1002/bjs.10400
Lee WJ, Chong K, Lin YH, Wei JH, Chen SC (2014) Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Obes Surg 24(9):1552–1562
pubmed: 24965545
doi: 10.1007/s11695-014-1344-5
Lundell L, Ruth M, Olbe L (1997) Vertical banded gastroplasty or gastric banding for morbid obesity: effects on gastro-oesophageal reflux. Eur J Surg 163(7):525–531
pubmed: 9248987
Morino M, Toppino M, Bonnet G, del Genio G (2003) Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial. Ann Surg 238(6):835–41
pubmed: 14631220
pmcid: 1356165
doi: 10.1097/01.sla.0000098627.18574.72
Musella M, Vitiello A, Berardi G, Velotti N, Pesce M, Sarnelli G (2021) Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trial. Surg Endosc 35(12):6777–6785
pubmed: 33269429
doi: 10.1007/s00464-020-08182-3
Nguyen NT, Kim E, Vu S, Phelan M (2018) Ten-year outcomes of a prospective randomized trial of laparoscopic gastric bypass versus laparoscopic gastric banding. Ann Surg 268(1):106–113
pubmed: 28692476
doi: 10.1097/SLA.0000000000002348
Nilsell K, Thörne A, Sjöstedt S, Apelman J, Pettersson N (2001) Prospective randomised comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. Eur J Surg 167(7):504–509
pubmed: 11560385
doi: 10.1080/110241501316914876
Olbers T, Fagevik-Olsén M, Maleckas A, Lönroth H (2005) Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty for obesity. Br J Surg 92(5):557–562
pubmed: 15810049
doi: 10.1002/bjs.4974
Ramón JM, Salvans S, Crous X et al (2012) Effect of Roux-en-Y gastric bypass vs sleeve gastrectomy on glucose and gut hormones: a prospective randomised trial. J Gastrointest Surg 16(6):1116–1122
pubmed: 22402955
doi: 10.1007/s11605-012-1855-0
Risstad H, Søvik TT, Engström M et al (2015) Five-year outcomes after laparoscopic gastric bypass and laparoscopic duodenal switch in patients with body mass index of 50 to 60: a randomized clinical trial. JAMA Surg 150(4):352–361
pubmed: 25650964
doi: 10.1001/jamasurg.2014.3579
Scozzari G, Farinella E, Bonnet G, Toppino M, Morino M (2009) Laparoscopic adjustable silicone gastric banding vs laparoscopic vertical banded gastroplasty in morbidly obese patients: long-term results of a prospective randomized controlled clinical trial. Obes Surg 19(8):1108–1115
pubmed: 19513797
doi: 10.1007/s11695-009-9871-1
Talebpour M, Sadid D, Talebpour A, Sharifi A, Davari FV (2018) Comparison of short-term effectiveness and postoperative complications: laparoscopic gastric plication vs laparoscopic sleeve gastrectomy. Obes Surg 28(4):996–1001
pubmed: 29043548
doi: 10.1007/s11695-017-2951-8
Werling M, Fändriks L, Björklund P et al (2013) Long-term results of a randomized clinical trial comparing Roux-en-Y gastric bypass with vertical banded gastroplasty. Br J Surg 100(2):222–230
pubmed: 23180572
doi: 10.1002/bjs.8975
MacLean LD, Rhode BM, Sampalis J, Forse RA (1993) Results of the surgical treatment of obesity. Am J Surg 165(1):155–60
pubmed: 8418692
doi: 10.1016/S0002-9610(05)80420-9
Jung SH, Yoon JH, Choi HS et al (2020) Comparative efficacy of bariatric endoscopic procedures in the treatment of morbid obesity: a systematic review and network meta-analysis. Endoscopy 52(11):940–954
pubmed: 32325513
doi: 10.1055/a-1149-1862
Abu Dayyeh BK, Bazerbachi F, Vargas EJ et al (2022) Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet 400(10350):441–451
pubmed: 35908555
doi: 10.1016/S0140-6736(22)01280-6
Abu Dayyeh BK, Maselli DB, Rapaka B et al (2021) Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Lancet 398(10315):1965–1973
pubmed: 34793746
doi: 10.1016/S0140-6736(21)02394-1
Caiazzo R, Branche J, Raverdy V et al (2020) Efficacy and safety of the Duodeno-Jejunal bypass liner in patients with metabolic syndrome: a multicenter randomized controlled trial (ENDOMETAB). Ann Surg 272(5):696–702
pubmed: 32889869
doi: 10.1097/SLA.0000000000004339
Chan DL, Cruz JR, Mui WL, Wong SKH, Ng EKW (2021) Outcomes with intra-gastric balloon therapy in BMI < 35 non-morbid obesity: 10-year follow-up study of an RCT. Obes Surg 31(2):781–786
pubmed: 33034015
doi: 10.1007/s11695-020-04986-3
Courcoulas A, Abu Dayyeh BK, Eaton L et al (2017) Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int J Obes (Lond) 41(3):427–433
pubmed: 28017964
doi: 10.1038/ijo.2016.229
Dargent J, Mion F, Costil V et al (2015) Multicenter randomized study of obesity treatment with minimally invasive injection of hyaluronic acid versus and combined with intragastric balloon. Obes Surg 25(10):1842–1847
pubmed: 25812529
doi: 10.1007/s11695-015-1648-0
Fuller NR, Pearson S, Lau NS et al (2013) An intragastric balloon in the treatment of obese individuals with metabolic syndrome: a randomized controlled study. Obesity (Silver Spring) 21(8):1561–1570
pubmed: 23512773
doi: 10.1002/oby.20414
Glaysher MA, Mohanaruban A, Prechtl CG et al (2017) A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. BMJ Open 7(11):e018598
pubmed: 29146657
pmcid: 5695522
doi: 10.1136/bmjopen-2017-018598
Koehestanie P, de Jonge C, Berends FJ, Janssen IM, Bouvy ND, Greve JW (2014) The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg 260(6):984–992
pubmed: 25072436
doi: 10.1097/SLA.0000000000000794
Mittermair R, Keller C, Geibel J (2007) Intragastric injection of botulinum toxin A for the treatment of obesity. Obes Surg 17(6):732–736
pubmed: 17879570
doi: 10.1007/s11695-007-9135-x
Ponce J, Woodman G, Swain J et al (2015) The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity. Surg Obes Relat Dis 11(4):874–881
pubmed: 25868829
doi: 10.1016/j.soard.2014.12.006
Rodriguez L, Reyes E, Fagalde P et al (2009) Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther 11(11):725–732
pubmed: 19905889
doi: 10.1089/dia.2009.0063
Ruban A, Miras AD, Glaysher MA et al (2022) Duodenal-Jejunal bypass liner for the management of type 2 diabetes mellitus and obesity: a multicenter randomized controlled trial. Ann Surg 275(3):440–447
pubmed: 34647708
doi: 10.1097/SLA.0000000000004980
Sullivan S, Stein R, Jonnalagadda S, Mullady D, Edmundowicz S (2013) Aspiration therapy leads to weight loss in obese subjects: a pilot study. Gastroenterology 145(6):1245-52.e1–5
pubmed: 24012983
doi: 10.1053/j.gastro.2013.08.056
Sullivan S, Swain JM, Woodman G et al (2017) Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. Obesity (Silver Spring) 25(2):294–301
pubmed: 28000425
doi: 10.1002/oby.21702
Sheppard CE, Lester EL, Chuck AW, Birch DW, Karmali S, de Gara CJ (2013) The economic impact of weight regain. Gastroenterol Res Pract 2013:379564
pubmed: 24454339
pmcid: 3888714
doi: 10.1155/2013/379564
Jensen AB, Renström F, Aczél S, et al (2023) Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery a Retrospective Observational Study. Obes Surg 33(4):1017-1025. https://doi.org/10.1007/s11695-023-06484-8 .
Chierici A, Chevalier N, Iannelli A (2022) Postoperative morbidity and weight loss after revisional bariatric surgery for primary failed restrictive procedure A systematic review and network meta-analysis. Int J Surg 102:106677
doi: 10.1016/j.ijsu.2022.106677
Kermansaravi M, Davarpanah Jazi AH, Shahabi Shahmiri S, Eghbali F, Valizadeh R, Rezvani M (2021) Revision procedures after initial Roux-en-Y gastric bypass, treatment of weight regain: a systematic review and meta-analysis. Updates Surg 73(2):663–678
pubmed: 33428184
doi: 10.1007/s13304-020-00961-w
Velotti N, Vitiello A, Berardi G, Di Lauro K, Roux-en-Y Musella M (2021) Gastric bypass versus one anastomosis-mini gastric bypass as a rescue procedure following failed restrictive bariatric surgery A systematic review of literature with metanalysis. Updates Surg 73(2):639–47
pubmed: 33606148
doi: 10.1007/s13304-020-00938-9
Aiolfi A, Micheletto G, Marin J, Bonitta G, Lesti G, Bona D (2020) Resleeve for failed laparoscopic sleeve gastrectomy: systematic review and meta-analysis. Surg Obes Relat Dis 16(10):1383–1391
pubmed: 32682774
doi: 10.1016/j.soard.2020.06.007
Purohit AM, Oyeka CP, Khan SS et al (2023) Preventing adverse cardiovascular outcomes in pregnancy complicated by obesity. Curr Obstet Gynecol Rep 12:129–137. https://doi.org/10.1007/s13669-023-00356-9
doi: 10.1007/s13669-023-00356-9
pubmed: 37840644
pmcid: 10575259
Sandsæter HL, Eik-Nes TT, Getz LO et al (2024) Weight development from childhood to motherhood—embodied experiences in women with pre-pregnancy obesity: a qualitative study. Reprod Health 21:15. https://doi.org/10.1186/s12978-024-01742-z
doi: 10.1186/s12978-024-01742-z
pubmed: 38291504
pmcid: 10826130
Navaee M, Kashanian M, Kabir A et al (2024) Maternal and fetal/neonatal outcomes in pregnancy, delivery and postpartum following bariatric surgery and comparison with pregnant women with obesity: a study protocol for a prospective cohort. Reprod Health 21:8. https://doi.org/10.1186/s12978-023-01736-3
doi: 10.1186/s12978-023-01736-3
pubmed: 38233940
pmcid: 10795358
Lane A, Wilcox S, Wingard E et al (2023) Association of a lifestyle intervention with blood pressure trajectories during pregnancy and postpartum in women with pre-pregnancy overweight and obesity. Matern Child Health J 27:1407–1415. https://doi.org/10.1007/s10995-023-03709-1
doi: 10.1007/s10995-023-03709-1
pubmed: 37266858
pmcid: 11064890